Enanta Pharmaceuticals In... (ENTA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

6.06

0.00%

After-hours Dec 13, 2024, 07:23 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Revenue	67.64M	79.20M	86.16M	97.07M	122.47M	205.20M	206.63M	102.81M	88.27M	160.88M	47.74M	32.05M	41.71M	41.88M	22.76M
Cost of Revenue	-	-	2.97M	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	67.64M	79.20M	83.19M	97.07M	122.47M	205.20M	206.63M	102.81M	88.27M	160.88M	47.74M	32.05M	41.71M	41.88M	22.76M
Operating Income	-121.69M	-137.21M	-123.84M	-109.57M	-41.64M	36.74M	88.33M	24.61M	30.84M	124.15M	18.98M	9.03M	21.29M	25.30M	6.94M
Interest Income	14.77M	11.36M	1.57M	2.02M	6.47M	8.82M	-	2.53M	1.74M	968.00K	467.00K	248.00K	118.00K	83.00K	14.00K
Pretax Income	-117.79M	-131.00M	-122.19M	-107.58M	-35.02M	45.56M	93.12M	26.95M	32.56M	125.45M	19.27M	9.63M	21.40M	23.31M	7.75M
Net Income	-116.05M	-133.82M	-121.75M	-79.00M	-36.17M	46.38M	71.96M	17.71M	21.67M	78.99M	34.44M	9.63M	21.40M	23.31M	7.90M
Selling & General & Admin	57.85M	52.89M	45.48M	32.54M	27.36M	26.25M	23.44M	20.75M	16.97M	13.54M	10.02M	6.18M	5.30M	5.04M	6.11M
Research & Development	131.48M	163.52M	164.52M	174.11M	136.76M	142.21M	94.86M	57.45M	40.46M	23.19M	18.74M	16.84M	15.12M	11.55M	9.72M
Other Expenses	-	-	83.00K	1.99M	6.62M	8.82M	4.79M	2.33M	1.72M	1.31M	283.00K	598.00K	-	5.04M	309.00K
Operating Expenses	189.33M	216.41M	210.00M	206.65M	164.11M	168.46M	118.30M	78.20M	57.43M	36.73M	28.76M	23.02M	20.42M	16.58M	15.82M
Interest Expense	10.94M	5.15M	1.57M	-	-	8.82M	4.85M	40.00K	45.00K	8.00K	18.00K	31.00K	-	3.16M	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	189.33M	216.41M	210.00M	206.65M	164.11M	168.46M	118.30M	78.20M	57.43M	36.73M	28.76M	23.02M	20.42M	16.58M	15.82M
Income Tax	-1.74M	2.82M	-433.00K	-28.58M	1.15M	-826.00K	21.16M	9.24M	10.89M	46.46M	-15.17M	-221.00K	-	3.16M	-157.00K
Shares Outstanding (Basic)	21.16M	20.97M	20.60M	20.17M	19.94M	19.58M	20.65M	19.07M	18.93M	18.67M	18.36M	9.79M	1.16M	1.16M	12.75M
Shares Outstanding (Diluted)	21.16M	20.97M	20.60M	20.17M	19.94M	20.97M	20.65M	19.41M	19.22M	19.30M	19.18M	9.79M	2.64M	2.64M	14.13M
EPS (Basic)	-5.48	-6.38	-5.91	-3.92	-1.81	2.37	3.48	0.93	1.14	4.23	1.88	-0.67	1.18	1.35	0.02
EPS (Diluted)	-5.48	-6.38	-5.91	-3.92	-1.81	2.21	3.48	0.91	1.13	4.09	1.80	-0.67	0.52	0.59	0.02
EBITDA	-104.51M	-123.48M	-119.22M	-104.25M	-37.99M	40.00M	90.85M	26.75M	32.50M	124.79M	19.34M	9.25M	21.57M	26.97M	8.30M
Depreciation & Amortization	2.34M	2.37M	2.97M	3.33M	3.64M	3.26M	2.52M	2.14M	1.66M	639.00K	352.00K	221.00K	172.00K	499.00K	553.00K